NEWS

News

October

Philogen announces the authorisation of a clinical trial with PHC-102 for the imaging of renal cell carcinoma.

  Philogen announces the authorisation of a clinical trial with PHC-102 for the imaging of renal cell carcinoma.




Philogen announces authorization from FDA of a pivotal registration trial in USA for the treatment of resectable melanoma
 

  Philogen announces authorization from FDA of a pivotal registration trial in USA

August

Philogen announces research collaboration with Servier in the field of DNA-encoded chemistry.

  Philogen announces research collaboration with Servier in the field of DNA-encoded chemistry

July

Philogen S.p.A. enters into Multi-Target research agreement with Boehringer Ingelheim in the field of DNA-encoded chemistry.

  Philogen S.p.A. enters into Multi-Target research agreement with Boehringer Ingelheim in the fiels of DNA-encoded chemistry.

May

Philogen S.p.A. announces participation to the ““FOCIS Annual Meeting 2017”, June  14 – 17, 2017, Chicago, USA

  Philogen S.p.A. announces participation to the ““FOCIS Annual Meeting 2017”


Philogen S.p.A. announces participation to the “5th Heidelberg Forum for Young Life Scientists”, June 8 – 9, 2017, Heidelberg, Germany

  Philogen S.p.A. announces participation to the “5th Heidelberg Forum for Young Life Scientists”


Philogen S.p.A. announces the publication in the prestigious Chemistry: A European Journal of a communication entitled: "A specific and covalent JNK-1 ligand selected from an encoded self-assembling chemical library"

  Philogen S.p.A announces the publication in the prestigious Chemistry: A European Journal

February

Philogen S.p.A. announces participation to the “CHI Immuno-Oncology Summit Europe”, March 20 – 24, 2017, London, UK

  Philogen S.p.A. announces participation to the “CHI Immuno-Oncology Summit Europe"


Philogen S.p.A. announces participation to the “7th annual World ADC Berlin meeting”, February 20 – 22, 2017, Berlin, Germany

  Philogen S.p.A. announces participation to the “7th annual World ADC Berlin meeting”


Philogen S.p.A. announces participation to the “PEGS Boston – The Essential Protein Engineering Summit (2017)”, May 1 – 5, 2017, Boston, USA

  Philogen S.p.A. announces participation to the “PEGS Boston – The Essential Protein Engineering Summit (2017)”

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy
X